HEXAMETHYLMELAMINE - A REVIEW

被引：5

作者：

HAHN, DA ^{[1
]}

BLACK, C ^{[1
]}

机构：

[1] PURDUE UNIV,SCH PHARM & PHARM SCI,W LAFAYETTE,IN 47907

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1980年 / 14卷 / 09期

关键词：

D O I：

10.1177/106002808001400902

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：591 / 598

页数：8

共 67 条

[1]

ALBERTS DS, 1979, CANCER TREAT REP, V63, P301

[2]

AMES MM, 1979, CANCER RES, V39, P5016

[3]

BENNETT JM, 1977, CANCER TREAT REP, V61, P1079

[4]

BERGEVIN PR, 1973, CANCER CHEMOTH REP 1, V57, P51

[5]

BLUM RH, 1973, EUR J CANCER, V9, P977

[6]

BONOMI P, 1978, P AM ASSOC CANC RES, V19, P335

[7] HEXAMETHYLMELAMINE TREATMENT OF SARCOMAS AND LYMPHOMAS [J].

BORDEN, EC ;

LARSON, P ;

ANSFIELD, FJ ;

BRYAN, GT ;

JOHNSON, RO ;

RAMIREZ, G ;

WILSON, WL .

MEDICAL AND PEDIATRIC ONCOLOGY, 1977, 3 (04) :401-406

[8]

BROWER MS, 1979, P AM ASSOC CANC RES, V20, P186

[9]

BRUCKNER HW, 1978, P AM ASSOC CANC RES, V19, P373

[10]

BRYAN GT, 1968, CLIN PHARMACOL THER, V9, P777